A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
March 2-3 | Virtual & Orlando, FL The University of Florida College of Pharmacy has partnered with GenomeWeb's Precision Medicine Leaders’ Summit to produce this event, which will be in-person […]
Thursday, March 2 | 8-9:30 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
GMKB